Exact Mass: 335.14

Exact Mass Matches: 335.14

Found 111 metabolites which its exact mass value is equals to given mass value 335.14, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-acetylglucosaminylasparagine

(2S)-2-amino-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl}propanoic acid

C12H21N3O8 (335.1329)


Aspartylglycosamine, also known as n4-(beta-N-acetyl-D-glucosaminyl)-L-asparagine or 1-beta-aspartyl-N-acetyl-D-glucosaminylamine, is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Aspartylglycosamine is soluble (in water) and a moderately acidic compound (based on its pKa). Aspartylglycosamine can be found primarily in urine, as well as in human spleen tissue. Within the cell, aspartylglycosamine is primarily located in the cytoplasm. Moreover, aspartylglycosamine is found to be associated with aspartylglucosaminuria, which is an inborn error of metabolism. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria corresponding to decreased activity of aspartylglycosamine amido hydrolase. Large amount of aspartylglycosamine appears in patients with aspartylglycosaminuria, which is a metabolic disorder associated with decreased activity of aspartylglycosamine amido hydrolase. [HMDB]

   

Tryptophyl-Methionine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-4-(methylsulphanyl)butanoic acid

C16H21N3O3S (335.1304)


Tryptophyl-Methionine is a dipeptide composed of tryptophan and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Methionyl-Tryptophan

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


Methionyl-Tryptophan is a dipeptide composed of methionine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Diethylenetriaminetetraacetic acid

2-{[2-({2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid

C12H21N3O8 (335.1329)


   

Ramixotidine

N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulphanyl]ethyl}-1-oxo-1-pyridine-3-carboximidic acid

C16H21N3O3S (335.1304)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

3-[(2-Aminoethylamino)methyl]-3-[bis(carboxymethyl)amino]pentanedioic acid

3-{[(2-aminoethyl)amino]methyl}-3-[bis(carboxymethyl)amino]pentanedioic acid

C12H21N3O8 (335.1329)


   

7,8-Dimethoxymyrtopsine

(+)-7,8-Dimethoxymyrtopsine

C17H21NO6 (335.1369)


   

Eremofortin E

Eremofortin E

C17H21NO6 (335.1369)


   
   

Hydroxylunidine

Hydroxylunidine

C17H21NO6 (335.1369)


   
   

hydroxymethylmycophenolic acid amide

hydroxymethylmycophenolic acid amide

C17H21NO6 (335.1369)


   

Araliopsinine

Araliopsinine

C17H21NO6 (335.1369)


   

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

3-[[2-Carboxy-2-(acetylamino)ethyl]thio]-4-hydroxynonanoic acid

C14H25NO6S (335.1403)


   

7-methoxycrinamabine

7-methoxycrinamabine

C17H21NO6 (335.1369)


   

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

7-((S)-2,3-Dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]chinolin-8-on|7-((S)-2,3-dihydroxy-3-methyl-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Hydroxylunidin|Hydroxylunidine|Isoorixin|isoorixine

C17H21NO6 (335.1369)


   
   
   
   
   
   
   
   
   
   
   
   
   

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

3,N4-4-Oxo-2-hexenal-5-methyl-deoxycytidine

C16H21N3O5 (335.1481)


   
   
   
   
   
   
   

Aspartylglycosamine

Aspartylglycosamine

C12H21N3O8 (335.1329)


   

Met-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H21N3O3S (335.1304)


A dipeptide formed from L-methionine and L-tryptophan residues.

   

TRP-Met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3S (335.1304)


   

Methionyltryptophan

Methionyltryptophan

C16H21N3O3S (335.1304)


   

panadiplon

panadiplon

C18H17N5O2 (335.1382)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline

C17H22ClN3O2 (335.14)


   

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(1-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14)


   

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

2-Methyl-2-propanyl 3-(6-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-1- piperidinecarboxylate

C17H22ClN3O2 (335.14)


   

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

1-Benzyl-4-(3-trifuoromethyl)phenyl-4-piperdinol

C19H20F3NO (335.1497)


   

Isoetharine mesylate

4-[1-HYDROXY-2-([1-METHYLETHYL]AMINO)BUTYL]-1,2-BENZENEDIOL METHANESULFONATE

C14H25NO6S (335.1403)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Isoetharine (Isoetarine) mesylate is an orally active selective agonist of β-adrenergic receptors. Isoetharine mesylate is a catechol-like agent and catechol O-methyltransferase (COMT) mediates its methylation. Isoetharine mesylate can promote the production of cAMP which stimulates the relaxation of smooth muscle cells and can be used as an emphysema, bronchitis and bronchodilator[1][2].

   

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

Ethyl 2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate

C21H18FNO2 (335.1321)


   

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

N-([1,1-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

C24H17NO (335.131)


   

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

2-Dibenzofuranamine, N-[1,1-biphenyl]-4-yl

C24H17NO (335.131)


   

Boxidine

1-[2-[4-[4-(trifluoromethyl)phenyl]phenoxy]ethyl]pyrrolidine

C19H20F3NO (335.1497)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

1-(9-ANTHRACENYLMETHYL)-4-PHENYL-1H-[1,2,3]TRIAZOLE

C23H17N3 (335.1422)


   

L-Methionine, L-tryptophyl-

L-Methionine, L-tryptophyl-

C16H21N3O3S (335.1304)


   

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-[2-(4-methoxyphenyl)ethyl]-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C18H17N5O2 (335.1382)


   

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

Tert-Butyl 4-(3-Thiophen-2-Yl-1,2,4-Oxadiazol-5-Yl)piperidine-1-Carboxylate

C16H21N3O3S (335.1304)


   

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

3-[1-(4-Carbamimidoylphenyl)triazol-4-yl]-4-methoxybenzenecarboximidamide

C17H17N7O (335.1495)


   

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine zwitterion

C12H21N3O8 (335.1329)


Zwitterionic form of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

a Steroid sulfate

a Steroid sulfate

C18H23O4S- (335.1317)


   

Diaminobutyryl-citryl-ethanolamine

Diaminobutyryl-citryl-ethanolamine

C12H21N3O8 (335.1329)


   

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

(2R,3S,9R)-5-acetyl-8,8-dimethyl-6-oxo-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),4,11(18),12,14-pentaen-4-olate

C20H19N2O3- (335.1396)


   

Illudacetalate

Illudacetalate

C18H23O6- (335.1495)


   

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

2-[2-[(3-Amino-3-carboxypropyl)amino]-2-oxoethyl]-4-(2-aminoethoxy)-2-hydroxy-4-oxobutanoic acid

C12H21N3O8 (335.1329)


   

BTCP hydrochloride

BTCP hydrochloride

C19H26ClNS (335.1474)


   

Thr-Thr-Asp

Thr-Thr-Asp

C12H21N3O8 (335.1329)


A tripeptide composed of two L-threonine units and L-aspartic acid joined by peptide linkages.

   

l-Prolyl-glycyl-l-tyrosine

l-Prolyl-glycyl-l-tyrosine

C16H21N3O5 (335.1481)


   

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

4-[1-[(3-Methoxy-4-methylphenyl)methyl]-2-benzimidazolyl]-1,2,5-oxadiazol-3-amine

C18H17N5O2 (335.1382)


   

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

(1Z)-1-[(6aR,11aS,11bR)-7,7-dimethyl-9,11-dioxo-2,6a,7,11,11a,11b-hexahydro-6H-pyrrolo[1,2:2,3]isoindolo[4,5,6-cd]indol-10(9H)-ylidene]ethanolate

C20H19N2O3- (335.1396)


   

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

N-[(1E)-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-3-fluorobenzohydrazide

C20H18FN3O (335.1434)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

4-Benzoyl-2,6-diphenylpyridine

4-Benzoyl-2,6-diphenylpyridine

C24H17NO (335.131)


   

N-Acetylglycylphenylalanylglycine methyl ester

N-Acetylglycylphenylalanylglycine methyl ester

C16H21N3O5 (335.1481)


   

N-Acetyl-glycyl-phenylalanyl-glycine methylester

N-Acetyl-glycyl-phenylalanyl-glycine methylester

C16H21N3O5 (335.1481)


   

N-Acetylglucosaminylasparagine

N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine

C12H21N3O8 (335.1329)


An N(4)-glycosyl-L-asparagine having (beta-N-acetyl-D-glucosaminyl as the glycosyl component.

   

tryptophylmethionine

tryptophylmethionine

C16H21N3O3S (335.1304)


   

alpha-cyclopiazonate

alpha-cyclopiazonate

C20H19N2O3 (335.1396)


An organic anion that is the conjugate base of alpha-cyclopiazonic acid; major species at pH 7.3.

   
   

AMPA receptor modulator-3

AMPA receptor modulator-3

C18H22FNO2S (335.1355)


AMPA receptor modulator-3 is an allosteric AMPA receptor modulator (EC50: 4.4 μM). AMPA receptor modulator-3 can be used in the research of mammalian nervous system, such as learning and memory[1][2].

   

Longdaysin

Longdaysin

C16H16F3N5 (335.1358)


Longdaysin is a inhibitor of the Wnt/β-catenin signaling pathway, which exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling. Longdaysin inhibits CK1α, CK1δ, CDK7, and ERK2 with IC50s of? 5.6 μM, 8.8 μM, 29 μM, and 52 μM, respectively[1][2].

   

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

n-({2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}methyl)ethanimidic acid

C16H21N3O3S (335.1304)


   

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2r,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1as,2s,3r,3'r,3ar,5s,7br)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

3-[(2r,3s)-3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl]-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

(2s)-2-{[(2s,3r)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-1,3-dihydroxybutylidene]amino}butanedioic acid

C12H21N3O8 (335.1329)


   

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

(1r,13s,16s,17r)-9-methoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol

C17H21NO6 (335.1369)


   

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

(2s)-2-amino-3-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]-c-hydroxycarbonimidoyl}propanoic acid

C12H21N3O8 (335.1329)


   

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-(2,3-dihydroxy-3-methylbutyl)-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2r,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

(1ar,2r,3r,3's,3ar,5r,7bs)-2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)


   

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

(2s,3s)-2-(2-hydroxypropan-2-yl)-4,7,8-trimethoxy-2h,3h-furo[2,3-b]quinolin-3-ol

C17H21NO6 (335.1369)


   

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

7-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-methoxy-9-methyl-2h-[1,3]dioxolo[4,5-h]quinolin-8-one

C17H21NO6 (335.1369)


   

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

n-{[(2s,4s)-2-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl]methyl}ethanimidic acid

C16H21N3O3S (335.1304)


   

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

(2s)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methylbutane-2,3-diol

C17H21NO6 (335.1369)


   

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

3-{3,7-dihydroxy-9-[(1-hydroxypropylidene)amino]-2,3,4,5-tetrahydro-1-benzoxepin-2-yl}-2-methylprop-2-enoic acid

C17H21NO6 (335.1369)


   

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

(3s,4r)-3,4-dihydroxy-7,8-dimethoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one

C17H21NO6 (335.1369)


   

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

2-(acetyloxy)-3,3',3a-trimethyl-6-oxo-2,3,4,7b-tetrahydro-1ah-spiro[naphtho[1,2-b]oxirene-5,2'-oxirane]-3'-carboximidic acid

C17H21NO6 (335.1369)